Quick Detail
Place of Origin
Brand Name
Jinlan
HS-CODE
-
Package & Delivery Lead Time
Package
1g,10g,20g,
Detailed Description
Description
Sofosbuvir is a nucleotide analog inhibitor of the hepatitis C virus (HCV) NS5B RNA‑dependent RNA polymerase. It acts as a chain terminator, blocking viral replication. It is a cornerstone of interferon‑free, oral direct‑acting antiviral (DAA) regimens for chronic hepatitis C.
Approved Indications
- Chronic hepatitis C virus (HCV) infection in adults and pediatric patients ≥3 years
- Used in combination regimens with other antivirals across HCV genotypes 1–6
Key Features
- High efficacy across all major HCV genotypes
- Once‑daily oral administration
- High barrier to resistance
- Short treatment duration (usually 12 weeks)
- Favorable safety profile
Applications
API, intermediates, reference standards for R&D, generic registration and commercial manufacturing.
China [CN] 
Click enlarge Image